Article thumbnail

Targeting SDF-1/CXCR4 to inhibit tumour vasculature for treatment of glioblastomas

By D Tseng, D A Vasquez-Medrano and J M Brown

Abstract

Local recurrence of glioblastomas is a major cause of patient mortality after definitive treatment. This review discusses the roles of the chemokine stromal cell-derived factor-1 and its receptor CXC chemokine receptor 4 (CXCR4) in affecting the sensitivity of glioblastomas to irradiation. Blocking these molecules prevents or delays tumour recurrence after irradiation by inhibiting the recruitment of CD11b+ monocytes/macrophages that participate in revascularising the tumour. We review the literature pertaining to the mechanism by which revascularisation occurs following tumour irradiation using experimental models. Areas of interest and debate in the literature include the process by which endothelial cells die after irradiation and the identity/origin of the cells that reconstitute the tumour blood vessels after injury. Understanding the processes that mediate tumour revascularisation will guide the improvement of clinical strategies for preventing recurrence of glioblastoma after irradiation

Topics: Minireview
Publisher: Nature Publishing Group
OAI identifier: oai:pubmedcentral.nih.gov:3111201
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. Chronic suppression of angiogenesis following radiation exposure is independent of hematopoietic reconstitution.
  2. (2006). CXCR4 inhibition synergizes with cytotoxic chemotherapy in gliomas.
  3. (2007). CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci USA 104(40): 15735–15740
  4. (2010). Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. JC l i nI n v e s t120(3): 694–705 Kollet
  5. (2006). Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes.